Content about National Institute of Allergy and Infectious Diseases

November 27, 2013

A new study is helping to provide a better understanding of vaccines for whooping cough, the Food and Drug Administration announced Wednesday.

SILVER SPRING, Md. — A new study is helping to provide a better understanding of vaccines for whooping cough, the Food and Drug Administration announced Wednesday. Based on an animal model, the study shows that acellular pertussis vaccines licensed by the FDA are effective in preventing the disease among those vaccinated, but suggests that they may not prevent infection from the bacteria that causes whooping cough in those vaccinated or its spread to other people, including those who may not be vaccinated.

September 29, 2010

British drug maker GlaxoSmithKline has stopped a late-stage trial of a vaccine for genital herpes,...

LONDON British drug maker GlaxoSmithKline has stopped a late-stage trial of a vaccine for genital herpes, citing disappointing results, GSK said Thursday.